Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity

Science Translational Medicine

Volumn 3, Issue 114, 2011, Pages

  OhAinle, Molly ^a   Balmaseda, Angel ^b   Macalalad, Alexander R ^c   Tellez, Yolanda ^b   Zody, Michael C ^c   Saborío, Saira ^b   Nuñez, Andrea ^b   Lennon, Niall J ^c   Birren, Bruce W ^c   Gordon, Aubree ^a   Henn, Matthew R ^c   Harris, Eva ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Ministry of Health   (Nicaragua)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4B; NONSTRUCTURAL PROTEIN 5;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CHILD; CLADISTICS; CONTROLLED STUDY; DENGUE; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; DISEASE SEVERITY; DISEASE TRANSMISSION; EPIDEMIC; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NICARAGUA; NUCLEOTIDE SEQUENCE; PHYLOGENY; POPULATION DYNAMICS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROPREVALENCE; SEROTYPE; THROMBOCYTE COUNT; UNINDEXED SEQUENCE; VIRAL GENETICS; VIRUS IMMUNITY; VIRUS ISOLATION; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE;

DENGUE; DENGUE VIRUS; HUMANS; MOLECULAR SEQUENCE DATA; SEVERITY OF ILLNESS INDEX;

EID: 84255168505     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3003084     Document Type: Article

References (95)

1. World Health Organization, Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control (World Health Organization, Geneva, ed. 2, 1997).
2. S. B. Halstead, Dengue. Lancet 370, 1644-1652 (2007).
3. N. Sangkawibha, S. Rojanasuphot, S. Ahandrik, S. Viriyapongse, S. Jatanasen, V. Salitul, B. Phanthumachinda, S. B. Halstead, Risk factors in dengue shock syndrome: A prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am. J. Epidemiol. 120, 653-669 (1984).
4. S. Thein, M. M. Aung, T. N. Shwe, M. Aye, A. Zaw, K. Aye, K. M. Aye, J. Aaskov, Risk factors in dengue shock syndrome. Am. J. Trop. Med. Hyg. 56, 566-572 (1997).
5. D. S. Burke, A. Nisalak, D. E. Johnson, R. M. Scott, A prospective study of dengue infections in Bangkok. Am. J. Trop. Med. Hyg. 38, 172-180 (1988).
6. M. G. Guzmán, G. Kouri, L. Valdes, J. Bravo, M. Alvarez, S. Vazques, I. Delgado, S. B. Halstead, Epidemiologic studies on dengue in Santiago de Cuba, 1997. Am. J. Epidemiol. 152, 793-799 (2000).
7. M. Alvarez, R. Rodriguez-Roche, L. Bernardo, S. Vázquez, L. Morier, D. Gonzalez, O. Castro, G. Kouri, S. B. Halstead, M. G. Guzman, Dengue hemorrhagic fever caused by sequential dengue 1-3 virus infections over a long time interval: Havana epidemic, 2001-2002. Am. J. Trop. Med. Hyg. 75, 1113-1117 (2006).
8. B. Hubert, S. B. Halstead, Dengue 1 virus and dengue hemorrhagic fever, French Polynesia, 2001. Emerg. Infect. Dis. 15, 1265-1270 (2009).
9. S. B. Halstead, Pathogenesis of dengue: Challenges to molecular biology. Science 239, 476-481 (1988).
10. A. B. Sabin, Research on dengue during World War II. Am. J. Trop. Med. Hyg. 1, 30-50 (1952).
11. T. J. Kochel, D. M. Watts, A. S. Gozalo, D. F. Ewing, K. R. Porter, K. L. Russell, Cross-serotype neutralization of dengue virus in Aotus nancymae monkeys. J. Infect. Dis. 191, 1000-1004 (2005).
12. S. B. Halstead, J. A. Suaya, D. S. Shepard, The burden of dengue infection. Lancet 369, 1410-1411 (2007).
13. M. G. Guzman, M. Alvarez, R. Rodriguez-Roche, L. Bernardo, T. Montes, S. Vazquez, L. Morier, A. Alvarez, E. A. Gould, G. Kouri, S. B. Halstead, Neutralizing antibodies after infection with dengue 1 virus. Emerg. Infect. Dis. 13, 282-286 (2007).
14. K. Boonnak, B. M. Slike, T. H. Burgess, R. M. Mason, S. J. Wu, P. Sun, K. Porter, I. F. Rudiman, D. Yuwono, P. Puthavathana, M. A. Marovich, Role of dendritic cells in antibody-dependent enhancement of dengue virus infection. J. Virol. 82, 3939-3951 (2008).
15. S. J. Balsitis, K. L. Williams, R. Lachica, D. Flores, J. L. Kyle, E. Mehlhop, S. Johnson, M. S. Diamond, P. R. Beatty, E. Harris, Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog. 6, e1000790 (2010).
16. S. B. Halstead, E. J. O'Rourke, Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J. Exp. Med. 146, 201-217 (1977).
17. R. M. Zellweger, T. R. Prestwood, S. Shresta, Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. Cell Host Microbe 7, 128-139 (2010).
18. A. L. Rothman, Dengue: Defining protective versus pathologic immunity. J. Clin. Invest. 113, 946-951 (2004).
19. I. Kurane, F. Ennis, Immunopathogenesis of dengue virus infection, in Dengue and Dengue Hemorrhagic Fever, D. J. Gubler, G. Kuno, Eds. (CAB International, New York, 1997), pp. 273-290.
20. A. L. Rothman, Immunity to dengue virus: A tale of original antigenic sin and tropical cytokine storms. Nat. Rev. Immunol. 11, 532-543 (2011).
21. H. J. Wearing, P. Rohani, Ecological and immunological determinants of dengue epidemics. Proc. Natl. Acad. Sci. U.S.A. 103, 11802-11807 (2006).
22. B. Adams, M. Boots, Modelling the relationship between antibody-dependent enhancement and immunological distance with application to dengue. J. Theor. Biol. 242, 337-346 (2006).
23. Y. Nagao, K. Koelle, Decreases in dengue transmission may act to increase the incidence of dengue hemorrhagic fever. Proc. Natl. Acad. Sci. U.S.A. 105, 2238-2243 (2008).
24. M. Recker, K. B. Blyuss, C. P. Simmons, T. T. Hien, B. Wills, J. Farrar, S. Gupta, Immunological serotype interactions and their effect on the epidemiological pattern of dengue. Proc. Biol. Sci. 276, 2541-2548 (2009).
25. R. R. Graham, M. Juffrie, R. Tan, C. G. Hayes, I. Laksono, C. Ma'roef, Erlin, Sutaryo, K. R. Porter, S. B. Halstead, A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia I. Studies in 1995-1996. Am. J. Trop. Med. Hyg. 61, 412-419 (1999).
26. M. G. Guzmán, G. P. Kouri, J. Bravo, M. Soler, S. Vazquez, L. Morier, Dengue hemorrhagic fever in Cuba, 1981: A retrospective seroepidemiologic study. Am. J. Trop. Med. Hyg. 42, 179-184 (1990).
27. S. C. Kliks, S. Nimmanitya, A. Nisalak, D. S. Burke, Evidence thatmaternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am. J. Trop. Med. Hyg. 38, 411-419 (1988).
28. S. B. Halstead, Neutralization and antibody-dependent enhancement of dengue viruses. Adv. Virus Res. 60, 421-467 (2003).
29. M. G. Guzmán, G. Kourí, L. Valdés, J. Bravo, S. Vázquez, S. B. Halstead, Enhanced severity of secondary dengue-2 infections: Death rates in 1981 and 1997 Cuban outbreaks. Rev. Panam. Salud Publica. 11, 223-227 (2002).
30. H. A. Stephens, R. Klaythong, M. Sirikong, D. W. Vaughn, S. Green, S. Kalayanarooj, T. P. Endy, D. H. Libraty, A. Nisalak, B. L. Innis, A. L. Rothman, F. A. Ennis, D. Chandanayingyong, HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens 60, 309-318 (2002).
31. J. A. Falcón-Lezama, C. Ramos, J. Zuñiga, L. Juárez-Palma, H. Rangel-Flores, A. R. García-Trejo, V. Acunha-Alonzo, J. Granados, G. Vargas-Alarcón, HLA class I and II polymorphisms in Mexican Mestizo patients with dengue fever. Acta Trop. 112, 193-197 (2009).
32. A. Sakuntabhai, C. Turbpaiboon, I. Casadémont, A. Chuansumrit, T. Lowhnoo, A. Kajaste-Rudnitski, S. M. Kalayanarooj, K. Tangnararatchakit, N. Tangthawornchaikul, S. Vasanawathana, W. Chaiyaratana, P.-T. Yenchitsomanus, P. Suriyaphol, P. Avirutnan, K. Chokephaibulkit, F. Matsuda, S. Yoksan, Y. Jacob, G. M. Lathrop, P. Malasit, P.Desprès, C. Julier, A variant in the CD209 promoter is associated with severity of dengue disease. Nat. Genet. 37, 507-513 (2005).
33. T. H. Nguyen, T. L. Nguyen, H Y. Lei, Y. S. Lin, B. L. Le, K. J. Huang, C. F. Lin, Q. H. Do, T. Q. Vu, T. M. Lam, T. M. Yeh, J. H. Huang, C. C. Liu, S. B. Halstead, Association between sex, nutritional status, severity of dengue hemorrhagic fever, and immune status in infants with dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 72, 370-374 (2005).
34. B. Sierra, R. Alegre, A. B. Pérez, G. García, K. Sturn-Ramirez, O. Obasanjo, E. Aguirre, M. Alvarez, R. Rodriguez-Roche, L. Valdés, P. Kanki, M.G. Guzmán,HLA-A, -B, -C, and -DRB1 allele frequencies in Cuban individuals with antecedents of dengue 2 disease: Advantages of the Cuban population for HLA studies of dengue virus infection. Hum. Immunol. 68, 531-540 (2007).
35. S. B. Halstead, T. G. Streit, J. G. Lafontant, R. Putvatana, K. Russell, W. Sun, N. Kanesa-Thasan, C. G. Hayes, D. M. Watts, Haiti: Absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission. Am. J. Trop. Med. Hyg. 65, 180-183 (2001).
36. U. Thisyakorn, S. Nimmannitya, Nutritional status of children with dengue hemorrhagic fever. Clin. Infect. Dis. 16, 295-297 (1993).
37. G. Garcia, B. Sierra, A. B. Pérez, E. Aguirre, I. Rosado, N. Gonzalez, A. Izquierdo, M. Pupo, D. R. Danay Díaz, L. Sánchez, B. Marcheco, K. Hirayama, M. G. Guzmán, Asymptomatic dengue infection in a Cuban population confirms the protective role of the RR variant of the FcgRIIa polymorphism. Am. J. Trop. Med. Hyg. 82, 1153-1156 (2010).
38. W. J. Barnes, L. Rosen, Fatal hemorrhagic disease and shock associated with primary dengue infection on a Pacific island. Am. J. Trop. Med. Hyg. 23, 495-506 (1974).
39. D. J. Gubler, D. Reed, L. Rosen, J. R. Hitchcock Jr., Epidemiologic, clinical, and virologic observations on dengue in the Kingdom of Tonga. Am. J. Trop. Med. Hyg. 27, 581-589 (1978).
40. D. J. Gubler, W. Suharyono, I. Lubis, S. Eram, S. Gunarso, Epidemic dengue 3 in central Java, associated with low viremia in man. Am. J. Trop. Med. Hyg. 30, 1094-1099 (1981).
41. D. J. Gubler, D. W. Trent, Emergence of epidemic dengue/dengue hemorrhagic fever as a public health problem in the Americas. Infect. Agents Dis. 2, 383-393 (1993).
42. G. P. Kouri, M. G. Guzmán, J. R. Bravo, C. Triana, Dengue haemorrhagic fever/dengue shock syndrome: Lessons from the Cuban epidemic, 1981. Bull. World Health Organ. 67, 375-380 (1989).
43. R. Rico-Hesse, L. M. Harrison, R. A. Salas, D. Tovar, A. Nisalak, C. Ramos, J. Boshell, M. T. de Mesa, R. M. Nogueira, A. T. da Rosa, Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology 230, 244-251 (1997).
44. R. Rico-Hesse, L. M. Harrison, A. Nisalak, D. W. Vaughn, S. Kalayanarooj, S. Green, A. L. Rothman, F. A. Ennis, Molecular evolution of dengue type 2 virus in Thailand. Am. J. Trop. Med. Hyg. 58, 96-101 (1998).
45. K. C. Leitmeyer, D. W. Vaughn, D. M. Watts, R. Salas, I. Villalobos, de Chacon, C. Ramos, R. Rico-Hesse, Dengue virus structural differences that correlate with pathogenesis. J. Virol. 73, 4738-4747 (1999).
46. S. N. Bennett, E. C. Holmes, M. Chirivella, D. M. Rodriguez, M. Beltran, V. Vorndam, D. J. Gubler, W. O. McMillan, Selection-driven evolution of emergent dengue virus. Mol. Biol. Evol. 20, 1650-1658 (2003).
47. S. N. Bennett, E. C. Holmes, M. Chirivella, D. M. Rodriguez, M. Beltran, V. Vorndam, D. J. Gubler, W. O. McMillan, Molecular evolution of dengue 2 virus in Puerto Rico: Positive selection in the viral envelope accompanies clade reintroduction. J. Gen. Virol. 87, 885-893 (2006).
48. A. Balmaseda, S. N. Hammond, L. Pérez, Y. Tellez, S. I. Saborío, J. C. Mercado, R. Cuadra, J. Rocha, M. A. Pérez, S. Silva, C. Rocha, E. Harris, Serotype-specific differences in clinical manifestations of dengue. Am. J. Trop. Med. Hyg. 74, 449-456 (2006).
49. C. Zhang, M. P. Mammen Jr., P. Chinnawirotpisan, C. Klungthong, P. Rodpradit, P. Monkongdee, S. Nimmannitya, S. Kalayanarooj, E. C. Holmes, Clade replacements in dengue virus serotypes 1 and 3 are associated with changing serotype prevalence. J. Virol. 79, 15123-15130 (2005).
50. K. L. McElroy, G. A. Santiago, N. J. Lennon, B. W. Birren, M. R. Henn, J. L. Muñoz-Jordan, Endurance, refuge, and reemergence of dengue virus type 2, Puerto Rico, 1986-2007. Emerg. Infect. Dis. 17, 64-71 (2011).
51. T. T. Vu, E. C. Holmes, V. Duong, T. Q. Nguyen, T. H. Tran, M. Quail, C. Churcher, J. Parkhill, J. Cardosa, J. Farrar, B. Wills, N. J. Lennon, B. W. Birren, P. Buchy, M. R. Henn, C. P. Simmons, Emergence of the Asian 1 genotype of dengue virus serotype 2 in Viet Nam: In vivo fitness advantage and lineage replacement in South-East Asia. PLoS Negl. Trop. Dis. 4, e757 (2010).
52. V. Duong, C. Simmons, L. Gavotte, A. Viari, S. Ong, N. Chantha, N. J. Lennon, B. W. Birren, S. Vong, J. J. Farrar, M. R. Henn, V. Deubel, R. Frutos, P. Buchy, Genetic diversity and lineage dynamic of dengue virus serotype 1 (DENV-1) in Cambodia. Infect. Genet. Evol. 10.1016/j.meegid.2011.06.019 (2011).
53. R. Rico-Hesse, Dengue virus virulence and transmission determinants. Curr. Top. Microbiol. Immunol. 338, 45-55 (2010).
54. D. M. Watts, K. R. Porter, P. Putvatana, B. Vasquez, C. Calampa, C. G. Hayes, S. B. Halstead, Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever. Lancet 354, 1431-1434 (1999).
55. N. Kanakaratne, W. M. Wahala, W. B. Messer, H. A. Tissera, A. Shahani, N. Abeysinghe, A. M. de-Silva, M. Gunasekera, Severe dengue epidemics in Sri Lanka, 2003-2006. Emerg. Infect. Dis. 15, 192-199 (2009).
56. E. Domingo, C. Escarmís, N. Sevilla, A. Moya, S. F. Elena, J. Quer, I. S. Novella, J. J. Holland, Basic concepts in RNA virus evolution. FASEB J. 10, 859-864 (1996).
57. D. H. Libraty, P. R. Young, D. Pickering, T. P. Endy, S. Kalayanarooj, S. Green, D. W. Vaughn, A. Nisalak, F. A. Ennis, A. L. Rothman, High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J. Infect. Dis. 186, 1165-1168 (2002).
58. D. W. Vaughn, S. Green, S. Kalayanarooj, B. L. Innis, S. Nimmannitya, S. Suntayakorn, T. P. Endy, B. Raengsakulrach, A. L. Rothman, F. A. Ennis, A. Nisalak, Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J. Infect. Dis. 181, 2-9 (2000).
59. P. Armstrong, R. Rico-Hesse, Differential susceptibility of Aedes aegypti to infection by the American and Southeast Asian genotypes of dengue type 2 virus. Vector Borne Zoonotic Dis. 1, 159-168 (2001).
60. P. M. Armstrong, R. Rico-Hesse, Efficiency of dengue serotype 2 virus strains to infect and disseminate in Aedes aegypti. Am. J. Trop. Med. Hyg. 68, 539-544 (2003).
61. R. Cologna, R. Rico-Hesse, American genotype structures decrease dengue virus output from human monocytes and dendritic cells. J. Virol. 77, 3929-3938 (2003).
62. R. Cologna, P. M. Armstrong, R. Rico-Hesse, Selection for virulent dengue viruses occurs in humans and mosquitoes. J. Virol. 79, 853-859 (2005).
63. J. Mota, R. Rico-Hesse, Humanized mice show clinical signs of dengue fever according to infecting virus genotype. J. Virol. 83, 8638-8645 (2009).
64. N. Vasilakis, E. J. Shell, E. B. Fokam, P. W. Mason, K. A. Hanley, D. M. Estes, S. C. Weaver, Potential of ancestral sylvatic dengue-2 viruses to re-emerge. Virology 358, 402-412 (2007).
65. T. J. Kochel, D. M. Watts, S. B. Halstead, C. G. Hayes, A. Espinoza, V. Felices, R. Caceda, C. T. Bautista, Y. Montoya, S. Douglas, K. L. Russell, Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever. Lancet 360, 310-312 (2002).
66. A. Balmaseda, E. Sandoval, L. Pérez, C. M. Gutiérrez, E. Harris, Application of molecular typing techniques in the 1998 dengue epidemic in Nicaragua. Am. J. Trop. Med. Hyg. 61, 893-897 (1999).
67. A. Balmaseda, S. N. Hammond, Y. Tellez, L. Imhoff, Y. Rodriguez, S. I. Saborío, J. C. Mercado, L. Perez, E. Videa, E. Almanza, G. Kuan, M. Reyes, L. Saenz, J. J. Amador, E. Harris, High seroprevalence of antibodies against dengue virus in a prospective study of schoolchildren in Managua, Nicaragua. Trop. Med. Int. Health 11, 935-942 (2006).
68. E. Harris, E. Videa, L. Pérez, E. Sandoval, Y. Téllez, M. L. Pérez, R. Cuadra, J. Rocha, W. Idiaquez, R. E. Alonso, M. A. Delgado, L. A. Campo, F. Acevedo, A. Gonzalez, J. J. Amador, A. Balmaseda, Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua. Am. J. Trop. Med. Hyg. 63, 5-11 (2000).
69. S. N. Hammond, A. Balmaseda, L. Pérez, Y. Tellez, S. I. Saborío, J. C. Mercado, E. Videa, Y. Rodriguez, M. A. Pérez, R. Cuadra, S. Solano, J. Rocha, W. Idiaquez, A. Gonzalez, E. Harris, Differences in dengue severity in infants, children, and adults in a 3-year hospital-based study in Nicaragua. Am. J. Trop. Med. Hyg. 73, 1063-1070 (2005).
70. A. Balmaseda, K. Standish, J. C. Mercado, J. C. Matute, Y. Tellez, S. Saborío, S. N. Hammond, A. Nuñez, W. Avilés, M. R. Henn, E. C. Holmes, A. Gordon, J. Coloma, G. Kuan, E. Harris, Trends in patterns of dengue transmission over 4 years in a pediatric cohort study in Nicaragua. J. Infect. Dis. 201, 5-14 (2010).
71. M. G. Guzmán, S. Vásquez, E. Martínez, M. Alvarez, R. Rodríguez, G. Kourí, J. de los Reyes, F. Acevedo, Dengue in Nicaragua, 1994: Reintroduction of serotype 3 in the Americas. Bol. Oficina Sanit. Panam. 121, 102-110 (1996).
72. M. E. Quiñones-Mateu, S. C. Ball, A. J. Marozsan, V. S. Torre, J. L. Albright, G. Vanham, G. van Der Groen, R. L. Colebunders, E. J. Arts, A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression. J. Virol. 74, 9222-9233 (2000).
73. G. S. Hall, D. P. Little, Relative quantitation of virus population size in mixed genotype infections using sequencing chromatograms. J. Virol. Methods 146, 22-28 (2007).
74. A. Balmaseda, S. N. Hammond, M. A. Pérez, R. Cuadra, S. Solano, J. Rocha, W. Idiaquez, E. Harris, Short report: Assessment of the World Health Organization scheme for classification of dengue severity in Nicaragua. Am. J. Trop. Med. Hyg. 73, 1059-1062 (2005).
75. A. Nisalak, T. P. Endy, S. Nimmannitya, S. Kalayanarooj, U. Thisayakorn, R. M. Scott, D. S. Burke, C. H. Hoke, B. L. Innis, D. W. Vaughn, Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. Am. J. Trop. Med. Hyg. 68, 191-202 (2003).
76. M. G. Guzman, G. Kouri, Dengue haemorrhagic fever integral hypothesis: Confirming observations, 1987-2007. Trans. R. Soc. Trop. Med. Hyg. 102, 522-523 (2008).
77. M. Kapoor, L. Zhang, M. Ramachandra, J. Kusukawa, K. E. Ebner, R. Padmanabhan, Association between NS3 and NS5 proteins of dengue virus type 2 in the putative RNA replicase is linked to differential phosphorylation of NS5. J. Biol. Chem. 270, 19100-19106 (1995).
78. B. Adams, E. C. Holmes, C. Zhang, M. P. Mammen Jr., S. Nimmannitya, S. Kalayanarooj, M. Boots, Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok. Proc. Natl. Acad. Sci. U.S.A. 103, 14234-14239 (2006).
79. E. C. Holmes, B. T. Grenfell, Discovering the phylodynamics of RNA viruses. PLoS Comput. Biol. 5, e1000505 (2009).
80. W. Avilés, O. Ortega, G. Kuan, J. Coloma, E. Harris, Integration of information technologies in clinical studies in Nicaragua. PLoS Med. 4, 1578-1583 (2007).
81. G. Kuan, A. Gordon, W. Avilés, O. Ortega, S. N. Hammond, D. Elizondo, A. Nuñez, J. Coloma, A. Balmaseda, E. Harris, The Nicaraguan Pediatric Dengue Cohort Study: Study design, methods, use of information technology, and extension to other infectious diseases. Am. J. Epidemiol. 170, 120-129 (2009).
82. K. Standish, G. Kuan, W. Avilés, A. Balmaseda, E. Harris, High dengue case capture rate in four years of a cohort study in Nicaragua compared to national surveillance data. PLoS Negl. Trop. Dis. 4, e633 (2010).
83. J. A. Colbert, A. Gordon, R. Roxelin, S. Silva, J. Silva, C. Rocha, E. Harris, Ultrasound measurement of gallbladder wall thickening as a diagnostic test and prognostic indicator for severe dengue in pediatric patients. Pediatr. Infect. Dis. J. 26, 850-852 (2007).
84. D. J. Gubler, G. Kuno, G. E. Sather, M. Velez, A. Oliver, Mosquito cell cultures and specific monoclonal antibodies in surveillance for dengue viruses. Am. J. Trop. Med. Hyg. 33, 158-165 (1984).
85. R. S. Lanciotti, C. H. Calisher, D. J. Gubler, G. J. Chang, A. V. Vorndam, Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J. Clin. Microbiol. 30, 545-551 (1992).
86. A. V. Vorndam, G. Kuno, Laboratory diagnosis of dengue virus infections, in Dengue and Dengue Hemorrhagic Fever, D. J. Gubler, G. Kuno, Eds. (CAB International, New York, 1997), pp. 313-333.
87. A. Balmaseda, M. G. Guzmán, S. Hammond, G. Robleto, C. Flores, Y. Téllez, E. Videa, S. Saborio, L. Pérez, E. Sandoval, Y. Rodriguez, E. Harris, Diagnosis of dengue virus infection by detection of specific immunoglobulin M (IgM) and IgA antibodies in serum and saliva. Clin. Diagn. Lab. Immunol. 10, 317-322 (2003).
88. R. J. Fernández, S. Vázquez, Serological diagnosis of dengue by an ELISA inhibition method (EIM). Mem. Inst. Oswaldo Cruz 85, 347-351 (1990).
89. J. D. Thompson, D. G. Higgins, T. J. Gibson, CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22, 4673-4680 (1994).
90. A. Stamatakis, RAxML-VI-HPC: Maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics 22, 2688-2690 (2006).
91. S. Guindon, O. Gascuel, A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst. Biol. 52, 696-704 (2003).
92. D. Posada, K. A. Crandall, MODELTEST: Testing the model of DNA substitution. Bioinformatics 14, 817-818 (1998).
93. Z. Yang, PAML 4: Phylogenetic analysis by maximum likelihood. Mol. Biol. Evol. 24, 1586-1591 (2007).
94. C. Ansarah-Sobrinho, S. Nelson, C. A. Jost, S. S. Whitehead, T. C. Pierson, Temperaturedependent production of pseudoinfectious dengue reporter virus particles by complementation. Virology 381, 67-74 (2008).
95. K. Mattia, B. A. Puffer, K. L. Williams, R. Gonzalez, M. Murray, E. Sluzas, D. Pagano, S. Ajith, M. Bower, E. Berduougo, E. Harris, B. J. Doranz, Dengue reporter virus particles for measuring neutralizing antibodies against each of the four dengue serotypes. PLoS One 6, e27252 (2011).